Oxford BioMedica received a buy rating and price target from Jefferies Financial Group, with ratings aggregated by MarketBeat.
2 reports, 1 independent
Updated Sep 4
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Oxford BioMedica received a buy rating and price target from Jefferies Financial Group, with ratings aggregated by MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Oxford BioMedica
bioTech Company
Nothing else this week.
-
Jefferies Financial Group
American financial services company
Related events
- Jefferies Financial Group boosted its price objective for MMM, with MarketBeat aggregating the consensus data.
- Financial firms including Truist, RBC, TD Cowen, and Jefferies issued various rating updates on October 30, 2026.
- Citigroup and Jefferies Financial Group provided analyst ratings and price targets for BHP Group stock.
- BHC received a 'hold' rating from Jefferies, while MarketBeat provided consensus data and the board initiated a stock buyback plan.
- MarketBeat aggregated sentiment data on Harmonic Inc.'s stock, while Jefferies Financial Group provided rating and price targets for the company.